SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-18-003225
Filing Date
2018-04-26
Accepted
2018-04-26 16:09:35
Documents
4
Period of Report
2018-06-07
Effectiveness Date
2018-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2235429zdef14a.htm DEF 14A 333766
2 G102608.JPG g102608.jpg GRAPHIC 5386
3 G30163BGI001.GIF g30163bgi001.gif GRAPHIC 93930
4 G30163BGI002.GIF g30163bgi002.gif GRAPHIC 87520
  Complete submission text file 0001047469-18-003225.txt   592485
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37467 | Film No.: 18778593
SIC: 2834 Pharmaceutical Preparations